Form 4: Hims & Hers CFO Exercises Options, Sells Shares

Hims & Hers Health, Inc. CFO Oluyemi Okupe executed a pre-planned stock option exercise and subsequent sale of Class A Common Stock.

Summary

• Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc., reported transactions involving the company's Class A Common Stock.
• On March 20, 2026, Okupe exercised stock options to acquire 4,489 shares of Class A Common Stock at an exercise price of $5.01 per share.
• Concurrently, Okupe sold 9,217 shares of Class A Common Stock at an average weighted price of $23.7677 per share, with prices ranging from $23.73 to $23.92.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025.
• Following these transactions, Okupe directly beneficially owns 318,789 shares of Class A Common Stock and indirectly owns 7,853 shares through a trust.
• Okupe also holds 139,562 stock options after the reported exercise.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. It's a routine, pre-planned insider transaction, which is expected. The CFO realizing a gain from options is a positive for the individual and reflects some stock appreciation, but the sale itself is not a direct indicator of company performance.

Positives

• The CFO realized a significant personal gain by exercising options at $5.01 and selling shares at an average of $23.7677, indicating a substantial profit from the company's stock appreciation.
• The transactions were executed under a Rule 10b5-1 trading plan, which demonstrates pre-planning and reduces concerns about opportunistic insider trading.

Negatives

• The sale of shares by a Chief Financial Officer, even if pre-planned, could be perceived by some investors as a lack of confidence, although the 10b5-1 plan mitigates this interpretation.

Risks

• NA

Future Outlook

This Form 4 filing reports past transactions and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those executed under a Rule 10b5-1 plan, are common for executives in publicly traded companies across various industries. These plans allow insiders to sell a predetermined number of shares at a predetermined time or price, providing liquidity while mitigating accusations of trading on material non-public information. This transaction is typical for a CFO realizing value from long-term equity compensation.

Comparison to Industry Standards

• The exercise of stock options and subsequent sale of shares by a CFO is a standard practice for executive compensation and wealth management, aligning with practices seen at comparable companies in the healthcare and technology sectors.
• The use of a Rule 10b5-1 trading plan is an industry best practice for insiders to manage their equity holdings in a compliant and transparent manner, similar to plans adopted by executives at companies like Teladoc Health (TDOC) or GoodRx (GDRX).

Stakeholder Impact

• Shareholders: The sale of shares by a CFO could be viewed as a minor liquidity event for the executive, with minimal direct impact on the company's operational or strategic direction. The pre-planned nature mitigates negative sentiment.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• NA

Key Dates

Recommendation

This Form 4 filing reports a routine, pre-planned insider transaction by the CFO, involving the exercise of stock options and subsequent sale of a portion of the acquired shares. While the CFO realized a significant gain, this is a personal financial event and does not provide new material information about the company's operational performance, strategic direction, or future prospects that would warrant a change in investment recommendation. The transaction was executed under a 10b5-1 plan, which is a standard practice for executives. Therefore, a seasoned investor would likely maintain their current position based solely on this filing, awaiting more comprehensive financial or strategic updates.

Keywords

HIMS, Hims & Hers Health, Oluyemi Okupe, CFO, Form 4, Insider Trading, Stock Option Exercise, Share Sale, 10b5-1 Plan